Author

Jeanne F. Noe

Observed names: J Noe, J.F. Noe, Jeanne Noe

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Observed institutions: University of North Carolina at Chapel Hill, City Of Hope National Medical Center, City of Hope, Duke Medical Center, UNC Lineberger Comprehensive Cancer Center

OpenAlex ID: A5058349965

Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study

2016 · Aaron D. Falchook, Gregg Tracton, et al. · Advances in Radiation Oncology · 46

ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

2020 · Steven I. Park, Thomas C. Shea, et al. · Blood Advances · 29

Genetic susceptibility to therapy-related leukemia after Hodgkin lymphoma or non-Hodgkin lymphoma: role of drug metabolism, apoptosis and DNA repair

2012 · Y Ding, C-L Sun, et al. · Blood Cancer Journal · 14

BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON‐BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL

2017 · S.I. Park, O. Olajide, et al. · Hematological Oncology · 7

Kinome reprogramming response to MEK inhibition: A window-of-opportunity trial in triple-negative breast cancer (TNBC).

2013 · Gary L. Johnson, Keith D. Amos, et al. · Journal of Clinical Oncology · 7

A Phase 2 Trial of Induction Chemotherapy with ABVD Followed By Brentuximab Vedotin Consolidation in Patients with Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma

2014 · Steven I. Park, Kristy L. Richards, et al. · Blood · 5

A phase 2 trial of ABVD followed by brentuximab vedotin consolidation in limited stage non-bulky Hodgkin lymphoma.

2016 · Steven I. Park, Oludamilola A. Olajide, et al. · Journal of Clinical Oncology · 4

Endocrine Therapy for Breast Cancer

2020 · Jeanne F. Noe, Margaret A. Bush · The Journal for Nurse Practitioners · 2

Immunotherapy and Targeted Drugs for Common Cancers

2020 · Peggy A. Bush, Jeanne F. Noe · The Journal for Nurse Practitioners · 1

Abstract P2-16-13: Phase I dose escalation clinical trial of the PI3K inhibitor BKM120 and capecitabine (C) in metastatic breast cancer (MBC)

2013 · EC Dees, PK Marcom, et al. · Cancer Research · 1

Breast Cancer Prevention

2012 · Jeanne F. Noe, Hyman B. Muss · 1

LCCC 1025: A phase II study evaluating the mTOR inhibitor everolimus with trastuzumab and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

2012 · Carey K. Anders, Allison Mary Deal, et al. · Journal of Clinical Oncology · 1

Works count: 12

Citation count: 118

H-index: 5

I10-index: 3